Equity Research Analyst – Healthcare

Il y a 2 jours

Brussels, Brussels-Capital, Belgique Keystone Group Temps plein
Role Overview We are seeking a Medical Doctor (MD)—specifically a physician with deep ties to Thailand and the broader ASEAN healthcare ecosystem—to join our Hong Kong-based family office as an Equity Research Analyst – Healthcare. Operating with permanent, patient capital and a multi-year investment horizon, our family office invests across global public equities (US, HKEX/China, Europe, Asia-Pacific) and select late-stage private healthcare companies. You will bridge clinical medicine and institutional capital allocation—translating scientific rigor, real-world clinical judgment, and regional ASEAN market insights into high-conviction investment theses for the Principal and Investment Committee. We actively welcome practicing or former clinicians who can demonstrate strong quantitative aptitude, financial literacy, and a passion for public and private markets

Key Responsibilities
Clinical & Scientific Due Diligence: Evaluate clinical trial designs, statistical endpoints, mechanism-of-action (MoA) differentiation, safety/tolerability profiles, and regulatory pathways (US FDA, EMA, NMPA, and ASEAN regulators) across global therapeutics, medtech, and diagnostics companies. ASEAN & Thailand Healthcare Coverage: Leverage on-the-ground networks across Thailand and Southeast Asia to track regional hospital operators, medical tourism trends, pharmaceutical distribution, specialty clinics, and cross-border expansion opportunities. Primary Research & KOL Engagement: Conduct peer-to-peer diligence with Key Opinion Leaders (KOLs), specialist physicians, hospital procurement heads, and C-suite executives at global medical conferences (e.g., ASCO, ESMO, AHA) and across Asia. Financial Modeling & Valuation: Build and maintain three-statement financial models, probability-adjusted Net Present Value (rNPV) drug/device pipeline models, sum-of-the-parts (SOTP) analyses, and DCF valuations (full training and mentorship provided for candidates transitioning directly from clinical practice). Investment Memos & IC Presentations: Author concise, thesis-driven investment memos detailing bull/bear scenarios, key clinical/commercial catalysts, variant perceptions, and downside risks; present recommendations directly to the CIO and Investment Committee. Private & Crossover Deal Evaluation: Partner with the private investments team to assess regional healthcare co-investments, pre-IPO rounds, and strategic partnerships between global biotechs and Asian healthcare providers. Qualifications & Experience
• Medical Credentials: Doctor of Medicine (MD) from a leading Thai or international medical school (e.g., Chulalongkorn, Mahidol/Siriraj/Ramathibodi, Chiang Mai, or accredited overseas institutions). Clinical residency, specialty training, or hospital practice experience is highly valued.
• Investment & Analytical Background: 2–5+ years of experience in clinical practice, healthcare consulting, venture capital, equity research, or healthcare corporate development Regional & Language Fluency:
• Native or full professional fluency in Thai and business-level fluency in English (essential for reading clinical literature, financial filings, and writing investment memos).
• Deep familiarity with Thailand’s public/private healthcare landscape, medical tourism dynamics, and ASEAN payer/reimbursement structures. Core Competencies & Mindset:
• Commercial Skepticism: Ability to distinguish between an impressive academic clinical result and a commercially viable product that doctors will actually prescribe or adopt.
• Quantitative Comfort: Strong analytical rigor and proficiency in Excel
• High Discretion & Long-Term Focus: Integrity, intellectual honesty, and discretion suited for a private family office environment.